Santarus (SNTS)
Santarus Revenue Growth: 101.1%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNTS Revenue Growth Rankings
| Overall | 96th percentile | 137 of 4363 |
| Sector | 90th percentile | 43 of 457 in Healthcare |
| Industry | 76th percentile | 30 of 126 in Biotechnology |
SNTS Revenue Growth Range, Past 5 Years
| Minimum | -58.56% | Dec 2010 |
| Maximum | 120.7% | Jun 2007 |
| Average | 30.25% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these SNTS related companies
SNTS News
$SNTS Mentioned more than normal on StockTwits - Currently at 7 x average daily social activity
about 3 days ago by TradeIdeasQuant
about 3 days ago by TradeIdeasQuant
$SNTS - Still long @ $4.75. Moved Trailing Stop @ $4.76 from 3 prior Stops - http://stks.co/41NS
about 3 days ago by TraderFoxxx
about 3 days ago by TraderFoxxx
8 breakouts: $AUTH, $RAI, $SNTS (gap). One sub-$1 and one $1-2. The number of breakouts slowly rising, but still a long way to go.
about 3 days ago by fallondpicks
about 3 days ago by fallondpicks
Canadian Imperial Bank of Commerce, Spreadtrum Communications Among Stocks Up on High Volume Tuesday
May 29, 12:33PM Fox Business
May 29, 12:33PM Fox Business
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting
May 18, 4:00AM Business Wire
May 18, 4:00AM Business Wire
Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
May 15, 8:19PM Seeking Alpha
May 15, 8:19PM Seeking Alpha
$SNTS - Still long @ $4.75. Current Trailing Stop @ $4.75 - http://stks.co/3m1j
about 22 days ago by TraderFoxxx
about 22 days ago by TraderFoxxx
$SNTS http://stks.co/3lXw from watch list over first line on volume of 18% full day average
about 22 days ago by StockTiger
about 22 days ago by StockTiger
Listen to $SNTS Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3jHb
about 24 days ago by earningscast
about 24 days ago by earningscast
Santarus to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 07, 4:00AM Business Wire
May 07, 4:00AM Business Wire
$SNTS nice move today!! they run drugs for my new postion $DEPO . hope she follows suit!
about 32 days ago by HighGrowthFinancial
about 32 days ago by HighGrowthFinancial
$SNTS filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3X57
about 36 days ago by MarketBrief
about 36 days ago by MarketBrief
Santarus to Hold First Quarter 2012 Financial Results Conference Call on May 8
Apr 26, 4:00AM Business Wire
Apr 26, 4:00AM Business Wire
$SNTS - Moved Trailing Stop higher to $4.75 from two prior Stops of $4.20 & $3.65 http://stks.co/3Vwh
about 37 days ago by TraderFoxxx
about 37 days ago by TraderFoxxx
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
Apr 10, 4:00AM Business Wire
Apr 10, 4:00AM Business Wire
Pharming and Hyupjin Corporation announce commercialisation agreement for RUCONEST in Korea
Mar 26, 1:03AM Thomson Reuters ONE
Mar 26, 1:03AM Thomson Reuters ONE
Santarus to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on March 5
Feb 27, 4:00AM Business Wire
Feb 27, 4:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNTS | 6.675 | +0.01 | +0.23% | 407.86M |
| SNTA | 5.11 | +0.30 | +6.24% | 277.20M |
| SNT | 0.245 | +0.01 | +6.52% | 21.13M |
| SGU | 3.93 | -0.02 | -0.51% | 242.14M |
| SGRP | 1.24 | +0.00 | +0.00% | 24.92M |
| SGOL | 160.51 | +5.92 | +3.83% | |
| SGNT | 15.98 | +0.03 | +0.19% | 444.69M |
| SGMS | 8.20 | -0.34 | -3.98% | 790.29M |
| SGMO | 4.23 | -0.21 | -4.73% | 233.37M |
| SGMA | 3.77 | -0.03 | -0.79% | 14.86M |